We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Reallocating Funds to Critical Path, Drug Safety in Fiscal 2007; Industry Faces New Fees
FDA Reallocating Funds to Critical Path, Drug Safety in Fiscal 2007; Industry Faces New Fees
February 10, 2006
The FDA wants to increase funding for influenza pandemic preparedness efforts, drug safety, the Critical Path Initiative and other priorities in fiscal 2007 by reassigning $52.3 million from various agency programs, according to a high-ranking agency official.